Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.

Jaspreet Kaur, Ursula I Tuor, Zonghang Zhao, Philip A Barber
Author Information
  1. Jaspreet Kaur: Department of Clinical Neurosciences, Experimental Imaging Centre and Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.

Abstract

Great uncertainty exists as to whether aging enhances the detrimental effects of tissue plasminogen activator (tPA) on vascular integrity of the ischemic brain. We hypothesized that tPA treatment would augment ischemic injury by causing increased blood-brain barrier (BBB) breakdown as determined by quantitative serial T(1) and T(2) magnetic resonance imaging (MRI), and the transfer constant for gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA) from blood to brain in aged (18 to 20 months) compared with young (3 to 4 months) Wistar rats after middle cerebral artery occlusion, mediated through the acute disassembly of claudin 5 and occludin. Increased T(2) values over the first hour of postreperfusion were independently augmented following treatment with tPA (P<0.001) and aging (P<0.01), supporting a synergistic effect of tPA on the aged ischemic brain. Blood-brain barrier permeability for Gd-DTPA (K(Gd)) was substantial following reperfusion in all animal groups and was exacerbated by tPA treatment in the elderly rat (P<0.001). The frequency of hematoma formation was proportionately increased in the elderly ischemic brain (P<0.05). Both tPA and age independently increased claudin 5 and occludin phosphorylation during ischemia. Early BBB permeability detected by quantitative MRI following ischemic stroke is enhanced by increased age and tPA and is related to claudin 5 and occludin phosphorylation.

References

  1. Pharmacol Rev. 2005 Jun;57(2):173-85 [PMID: 15914466]
  2. Int J Stroke. 2009 Jun;4(3):159-68 [PMID: 19659815]
  3. J Cereb Blood Flow Metab. 2009 May;29(5):1048-58 [PMID: 19319145]
  4. Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000213 [PMID: 19821269]
  5. Stroke. 2002 Jan;33(1):79-86 [PMID: 11779893]
  6. J Cereb Blood Flow Metab. 2010 May;30(5):900-3 [PMID: 20216551]
  7. Neurobiol Aging. 2006 Jan;27(1):98-104 [PMID: 16298245]
  8. BMJ. 2011 Jan 19;342:d306; author reply d312 [PMID: 21248009]
  9. Magn Reson Med. 1995 Dec;34(6):824-34 [PMID: 8598809]
  10. Stroke. 1995 Dec;26(12):2219-21 [PMID: 7491639]
  11. Cerebrovasc Dis. 2003;15(1-2):98-105 [PMID: 12499718]
  12. Magn Reson Imaging. 1994;12(3):403-11 [PMID: 8007769]
  13. Cerebrovasc Brain Metab Rev. 1994 Spring;6(1):47-96 [PMID: 8186069]
  14. Stroke. 2001 Nov;32(11):2486-91 [PMID: 11692005]
  15. Magn Reson Med. 2005 Oct;54(4):813-21 [PMID: 16142715]
  16. Magn Reson Med. 2003 Aug;50(2):283-92 [PMID: 12876704]
  17. Mech Ageing Dev. 2003 Feb;124(2):143-6 [PMID: 12633933]
  18. Biochem Biophys Res Commun. 2005 Feb 25;327(4):1114-23 [PMID: 15652512]
  19. Lancet. 2000 May 13;355(9216):1670-4 [PMID: 10905241]
  20. Acta Neuropathol. 2002 Mar;103(3):237-42 [PMID: 11907803]
  21. Stroke. 2005 Jun;36(6):1247-52 [PMID: 15879323]
  22. Diabetes. 1998 Dec;47(12):1953-9 [PMID: 9836530]
  23. J Cell Biol. 1998 Jun 29;141(7):1539-50 [PMID: 9647647]
  24. J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):317-21 [PMID: 12588915]
  25. J Neurochem. 2008 Sep;106(6):2395-409 [PMID: 18647175]
  26. N Engl J Med. 1995 Dec 14;333(24):1581-7 [PMID: 7477192]
  27. Thromb Haemost. 1981 Aug 28;46(2):561-5 [PMID: 6795744]
  28. Stroke. 2002 Mar;33(3):831-6 [PMID: 11872911]
  29. Stroke. 1998 Jan;29(1):144-51 [PMID: 9445344]
  30. J Cereb Blood Flow Metab. 2002 May;22(5):559-68 [PMID: 11973428]
  31. Stroke. 1996 Sep;27(9):1663-7; discussion 1668 [PMID: 8784145]
  32. Neurology. 2001 Apr 24;56(8):1015-20 [PMID: 11320171]
  33. Stroke. 2010 Aug;41(8):1833-5 [PMID: 20576948]
  34. J Magn Reson Imaging. 1993 Sep-Oct;3(5):746-54 [PMID: 8400561]
  35. J Cereb Blood Flow Metab. 2005 May;25(5):583-92 [PMID: 15716859]
  36. Stroke. 2008 Feb;39(2):427-32 [PMID: 18174480]
  37. Free Radic Biol Med. 2005 Jul 1;39(1):51-70 [PMID: 15925278]
  38. J Cell Biol. 2003 May 12;161(3):653-60 [PMID: 12743111]
  39. Stroke. 2007 Jan;38(1):75-9 [PMID: 17122437]
  40. J Neurosurg. 2005 Oct;103(4):687-94 [PMID: 16266051]
  41. J Biol Chem. 1951 Nov;193(1):265-75 [PMID: 14907713]

Grants

  1. /Canadian Institutes of Health Research

MeSH Term

Age Factors
Aging
Animals
Blood-Brain Barrier
Brain
Brain Ischemia
Claudin-5
Fibrinolytic Agents
Infarction, Middle Cerebral Artery
Magnetic Resonance Imaging
Male
Membrane Proteins
Occludin
Permeability
Rats
Rats, Wistar
Tissue Plasminogen Activator

Chemicals

Claudin-5
Cldn5 protein, rat
Fibrinolytic Agents
Membrane Proteins
Occludin
Ocln protein, rat
Tissue Plasminogen Activator

Word Cloud

Created with Highcharts 10.0.0tPAischemicbrainincreasedclaudin5occludinfollowingP<0treatmentbarrierTMRIpermeabilityelderlyagingtissueplasminogenactivatorblood-brainBBBquantitative2Gd-DTPAagedmonthsdisassemblyindependently001agephosphorylationrelatedGreatuncertaintyexistswhetherenhancesdetrimentaleffectsvascularintegrityhypothesizedaugmentinjurycausingbreakdowndeterminedserial1magneticresonanceimagingtransferconstantgadolinium-diethylenetriaminepenta-aceticacidblood1820comparedyoung34WistarratsmiddlecerebralarteryocclusionmediatedacuteIncreasedvaluesfirsthourpostreperfusionaugmented01supportingsynergisticeffectBlood-brainKGdsubstantialreperfusionanimalgroupsexacerbatedratfrequencyhematomaformationproportionately05ischemiaEarlydetectedstrokeenhancedQuantitativerevealssusceptibleearly

Similar Articles

Cited By